Public disclosures

Chernett Jorey

Company insiders · 10% owner · Neuronetics, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-13.Following & alerts
Reported transaction lines
20
Buy lines
11
Sell lines
9

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-1120

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 7325577 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.44, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-132026-11-13

≈ $2,515,108.65

2,187,051 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 9512628 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.54, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-122026-11-13

≈ $1,010,781.20

706,840 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 10219468 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.65, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-112026-11-13

≈ $139,678.77

86,757 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 10306225 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-092026-11-13

≈ $79,600.00

40,000 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 10266225 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $1.96 to $2.18, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-092026-11-13

≈ $214,155.54

103,959 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 10370184 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.56, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-062026-11-13

≈ $599,421.56

250,804 shares/units

SEC 4
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2529436 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-132026-11-13

≈ $236,917.44

58,068 shares/units

SEC 4
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2587504 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.95, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-122026-11-13

≈ $508,877.40

109,436 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Original filed 2026-11-12

Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 6391 · SEC code covers open-market or private transactions · The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer. · This Form 4/A is being filed solely to indicate that the Reporting Person is no longer subject to Section 16 reporting obligations and constitutes an exit filing for the Reporting Person.

2026-11-112026-11-13

1,391 shares/units

SEC 4/A

Amendment

Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2696940 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.82 to $5.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-112026-11-12

≈ $372,977.45

71,315 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 6391 · SEC code covers open-market or private transactions · The reported transaction is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transaction, which the reporting person intends to disgorge to the Issuer.

2026-11-112026-11-12

1,391 shares/units

SEC 4
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2625625 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-102026-11-10

≈ $37,267.10

7,085 shares/units

SEC 4
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2618540 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.26 to $7.00, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

2026-11-092026-11-10

≈ $53,975.00

8,500 shares/units

SEC 4
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2610040 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $5.86 to $6.18, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · This amount corrects a clerical error in the Reporting Person's previously filed Form 4 in which the number of shares beneficially owned by the Reporting Person was under-reported by 2,765 shares.

2026-11-062026-11-10

≈ $69,167.10

11,265 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Call Option (STLN 21MAY27 $5C) · Derivative security · Direct ownership · Reported balance after transaction: 7000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-102026-11-10

7,000 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Call Option (STLN 19FEB27 $5C) · Derivative security · Direct ownership · Reported balance after transaction: 7500 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased.

2026-11-092026-11-10

7,500 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Call Option (STLN 19FEB27 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 5000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-062026-11-10

5,000 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Call Option (STLN 20NOV26 $4C) · Derivative security · Direct ownership · Reported balance after transaction: 10000 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-062026-11-10

10,000 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 7858091 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

2026-11-092026-11-10

≈ $176,273.10

48,294 shares/units

SEC 4
Chernett Jorey

10% owner · Starling Oncology, Inc.

STLN

Starling Oncology, Inc.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 7809797 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-062026-11-10

≈ $11,375,733.39

2,851,061 shares/units

SEC 4
Chernett Jorey

10% owner · Neuronetics, Inc.

STIM

Neuronetics, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 10620988 · SEC code covers open-market or private transactions

2026-10-302026-11-02

≈ $40,860.00

18,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement